MDT & pathway
Lung cancer MDT form (v3.1)
Structured multidisciplinary team form with TNM staging support, Charlson comorbidity index, itemised G8 screening, and registry-coded fields. Exports to JSON/CSV. Runs locally; no data is stored.
MDT structured (mini)
A compact structured form covering the same items as the open form, with coded fields. Includes a Nordic language selector (English, Finnish, Swedish, Norwegian, Danish, Icelandic) — the summary follows the chosen language. Runs locally; no data is stored.
MDT free-text form
A narrative, free-text lung cancer MDT checklist adapted for Nordic use. A lighter, open-field alternative to the structured form. Includes the same Nordic language selector (6 languages). Runs locally; no data is stored.
Nodule management
Pan-Nordic pulmonary nodule follow-up guidance: risk assessment, diagnostic pathways, and reporting principles.
Screening & nodule risk — educational
LungRisk hub
Compare published lung cancer screening criteria and person-level risk and nodule models (USPSTF, NELSON, PLCOm2012, HUNT, Brock) for education and research. No clinical action threshold is defined.
Screening risk explained
A plain-language explanation of how lung cancer screening risk is estimated and what the numbers mean for patients and clinicians.
Nordic Nodule Pathway Sandbox
A research sandbox for pulmonary nodule pathway development — gap-population analysis, Euclidean grey-zone geometry, four-centroid mixture decomposition and decision-boundary robustness. Browser-only; not a medical device.
Treatment value & follow-up — educational
Understanding treatment value
An educational page explaining treatment-value concepts in thoracic oncology — overall survival, hazard ratio, absolute benefit, NNT, NNH, toxicity and quality of life.
Treatment Value Discussion Compass
Structure a balanced discussion of benefit, toxicity, quality of life, evidence certainty and patient goals for a treatment decision.
Structured Treatment Value Profile
Systematically capture an educational treatment-value profile across overall survival benefit, hazard ratio, absolute benefit, NNT, NNH and toxicity.
Surveillance yield — Number Needed to Scan
Estimate how many surveillance CTs are needed to detect one recurrence — or one actionable event — after lung cancer treatment, with a time-dependent recurrence hazard. Yield, not survival benefit.
Research builders
Nordic lung cancer trends
Compare NORDCAN incidence and mortality trends by country and sex, with explicit rate definitions, provenance and presentation-ready exports.
Lung cancer quality indicators
Review 57 candidate Nordic indicators, their definitions, evidence, provenance and relationships before Delphi selection.
Study design & simulation builder
Plan and simulate study designs — endpoints, assumptions and scenarios — for thoracic oncology research planning.
Federated dataset & visualisation builder
Build a federated dataset specification and visualisations for multicentre Nordic research collaboration.